Records containing: Solid Tumors
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2017-12-26A Phase I Dose-finding Study of E7050 Administered Orally to Patients With Advanced Solid Tumors.
-
CLINICAL_TRIALS study record update · 2017-12-18A Single-Center, Open-Label Study Investigating the Excretion Balance, Pharmacokinetics, Metabolism, and Absolute Oral Bioavailability of a Single Oral Dose of [14C]-Labeled Idasanutlin and an Intravenous Tracer Dose of [13C]-Labeled Idasanutlin in a Single Cohort of Patients With Solid Tumors
-
CLINICAL_TRIALS study record update · 2017-11-21A Phase I Study to Assess the Effect of a CYP3A Inducer (Rifampin) on the Pharmacokinetics of ABT-263 (Navitoclax)
-
CLINICAL_TRIALS study record update · 2017-11-21A Phase 1 Safety and Pharmacokinetic Study of ABT-263 in Combination With Gemzar® (Gemcitabine) in the Treatment of Subjects With Solid Tumors
-
CLINICAL_TRIALS study record update · 2017-11-21A Phase 1 Study Evaluating the Relative Oral Bioavailability of New Formulations of ABT-263 in Subjects With Cancer
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2017-11-21A Phase 1 Safety and Pharmacokinetic Study of ABT-263 in Combination With Paclitaxel in the Treatment of Subjects With Solid Tumors
-
CLINICAL_TRIALS study record update · 2017-11-21A Phase 1, Single-Dose, Randomized, Group Sequential Cross-Over Study Evaluating the Bioavailability and Food Effect of Three Formulations of Veliparib on Pharmacokinetics in Subjects With Solid Tumors
-
CLINICAL_TRIALS study record update · 2017-11-20A Randomized, Placebo-Controlled Crossover Study to Evaluate the Effect of Veliparib (ABT-888) on Cardiac Repolarization in Subjects With Relapsed or Refractory Solid Tumors
-
CLINICAL_TRIALS study record update · 2017-11-20A Phase 1 Study of Veliparib (ABT-888) in Combination With Carboplatin/Paclitaxel in Japanese Subjects With Solid Tumors
-
CLINICAL_TRIALS study record update · 2017-11-20A Phase 1 Study Evaluating the Safety and Pharmacokinetics of ABT-263 in Combination With Erlotinib and ABT-263 in Combination With Irinotecan, and Evaluating the Safety of ABT-263 Monotherapy in Subjects With Cancer
-
CLINICAL_TRIALS study record update · 2017-10-23A Phase 1 Dose-Escalation Study of the Safety, Pharmacokinetics, and Pharmacodynamics of the Cyclin-Dependent Kinase (CDK) Inhibitor SCH 727965 Administered Every 3 Weeks in Subjects With Advanced Malignancies
-
CLINICAL_TRIALS study record update · 2017-10-19A Phase 1 Dose Escalation Study of SCB01A in Subjects With Advanced Solid Tumors Who Have Failed Standard Therapy
-
CLINICAL_TRIALS study record update · 2017-10-04Phase I Study of the Hsp90 Inhibitor, PU-H71, in Patients With Refractory Solid Tumors and Low-Grade Non-Hodgkin's Lymphoma
-
CLINICAL_TRIALS study record update · 2017-10-02A Phase Ib Open Label Study of the Safety and Tolerability of ME-344 Given in Combination With Topotecan (Hycamtin®) in Patients With Solid Tumors
-
CLINICAL_TRIALS study record update · 2017-09-19International, Multi-Center, Open-label, Treatment Extension Study of Iniparib as Monotherapy or in Combination Chemotherapeutic Regimens in Cancer Patients Who Have Derived Clinical Benefit From Iniparib Following Completion of a Phase 1, 2 or 3 Parental Study
-
CLINICAL_TRIALS study record update · 2017-09-01Phase I Dose Escalation of Pazopanib Plus TH-302 in Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2017-08-01Phase I Study of Single Agent Perifosine for Recurrent Pediatric Solid Tumors
-
CLINICAL_TRIALS study record update · 2017-07-28A Phase 1 Study to Investigate the Absorption, Metabolism and Excretion of [14C]ASP8273 in Subjects With Solid Tumors Harboring Epidermal Growth Factor Receptor (EGFR) Mutations
-
CLINICAL_TRIALS study record update · 2017-07-19Reduced Intensity Haploidentical Transplantation With NK Cell Infusion for Pediatric Acute Leukemia and High Risk Solid Tumors, BMT06407
-
CLINICAL_TRIALS study record update · 2017-07-02A Phase I Trial and Pharmacokinetic Study of Trabectedin (YONDELIS [R], ET-743) in Children and Adolescents With Relapsed or Refractory Solid Tumors
-
CLINICAL_TRIALS study record update · 2017-07-02A Phase I Study of ABT-888 in Combination With Topotecan Hydrochloride in Adults With Refractory Solid Tumors and Lymphomas
-
CLINICAL_TRIALS study record update · 2017-07-02Phase I Study of CDDO in Solid Tumors and Lymphomas
-
CLINICAL_TRIALS study record update · 2017-06-23Phase I Dose Escalation Study of ON 01910.Na by 24 Hour Continuous Infusion Per Week in Patients With Advanced Cancer
-
CLINICAL_TRIALS study record update · 2017-06-23Phase I Dose Escalation Study of ON 01910.Na by 3-day Continuous Infusion in Patients With Advanced Cancer
-
CLINICAL_TRIALS study record update · 2017-06-23Phase I Dose Escalation Study of Gemcitabine and ON 01910.Na in Patients With Advanced or Metastatic Solid Tumors